CDSL growth is expected to resume led by a recovery in market-linked revenue (transaction, IPO, and KYC) and a strong annuity stream (annual issuer charges and e-CAS). Incremental revenue from compulsory Demat of new insurance policies (effective April 2024) and unlisted companies (Private Ltd) will provide a growth push in FY25E. The BO account addition is the core building block of the depository business and continued strong additions will support growth. CDSL added ~33mn accounts in FY24 (~0.13mn accounts every day) registering a growth of +39% YoY. It has a 76% BO market share with an 88% incremental share. We expect CDSL growth to be supported by (1) strong BO account additions, (2) traction in market-linked revenue, (3) a stable annuity revenue stream, and (4) contribution from CIRL. The insurance segment will contribute revenue of INR 0.31/0.35bn in FY25/26E assuming a 10/15% market share. We increase our EPS estimate by ~7/9% for FY25/26E, implying revenue/EBITDA/APAT CAGR of 21/24/23% over FY24-26E. We maintain our BUY rating and assign a TP of INR 2,360, based on 40x FY26E EPS. The stock has traded at an average 3Y/5Y 1-year forward P/E multiple of 42/35x. CDSL has a RoE of 32%, RoIC of 82%, 5Y average cash conversion is >80%, and net cash is ~6% of the market cap.
Subscribe to Blog via Email
Join 480 other subscribers
- Va Tech Wabag is a Buy for target price of ₹1700 (30% upside)Va Tech Wabag is ‘RIDING THE WAVE’. It is well-placed to serve the growing water security/conservation market. Rationale supported by a) Strong industry tailwinds, b) Improving profitability, c) Robust Order book, & d) Expanding offerings. TP ₹1700 (+30%) Download... Va Tech Wabag is a Buy for target price of ₹1700 (30% upside)
- Zomato is not overvalued & is still a good buy: Manish SonthaliaManish Sonthalia says there is no question of Zomato being overvalued though it is up 155% YoY. "The street will get surprised on numbers on FY26, FY27 & FY28. The Quick commerce of tripling of dark stores by FY26 is yet to play up”. Stay invested in stock [youtube https://www.youtube.com/watch?v=rVwYVaHV3oE]
- Even if only US shifts 20-30%, Indian API revenues could triple or quadruple in 10 yearsAditya Khemka says the US' Biosecure Act will benefit Pharma Cos like Piramal Pharma & Jubilant Pharmova which have mfg facilities in the US as they will be the first order beneficiary. Indian API exports are $4B while China's API exports are $40B. Even if only US shifts 20-30%, Indian API revenues could triple or […]
Recent Posts
- Federal Bank is a credible alternative to larger private sector banks. Buy for target price of ₹225 (22% upside): HDFC Sec
- VA Tech Wabag bagged a mammoth order of INR 27bn (equivalent to its FY24 revenue). Hold for target price of ₹1541 (17% upside): ICICI Securities
- Va Tech Wabag Ltd is ‘RIDING THE WAVE’. It is well-placed to serve the growing water security/conservation market. Buy for target price of ₹1700 (30% upside): Axis Securities
- Bajaj Housing Finance is an HFC to Own. It is the second largest, fast growing, most diversified and profitable HFC: Yes Securities
- High Conviction Stocks Portfolio by InCred Equities with up to 72% upside potential. Nifty 50 target is 26,736
Recent Comments
- anil on Ace Stock Picker Maheen Rahman Recommends Mega Multibagger Stocks Which Will Be “Next HDFC Bank, Kotak Bank”
- Shaileshbhai Rajwadi on Kenneth Andrade reveals his latest stock picks & strategy for 2024. He is very bullish about Pharma, Liquor and Metal stocks but is avoiding banking stocks
- Surineni Sudhakar on Sunil Singhania’s (Abakkus) purchase of 6.7% of Shriram Pistons appears to be because of its EV prospects
- Anil on Prashant Jain has invested in a portfolio of promising small and nano-cap stocks from different sectors.
- Anil on Prashant Jain has invested in a portfolio of promising small and nano-cap stocks from different sectors.
Leave a Reply